Durmuş Yıldıray Şahin
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Durmuş Yıldıray Şahin has a total of 94 co-authors. Here are the top co-authors by number of shared publications:
- Zafer Elbasan
Department of Cardiology, Adana Numune Education and Research Hospital, Adana 01150, Turkey
19 shared publications Mustafa Gür
Department of Cardiology, Adana Numune Education and Research Hospital, Adana 01150, Turkey
16 shared publicationsMurat Çaylı
Department of Cardiology, Adana Numune Education and Research Hospital, Adana 01150, Turkey
11 shared publicationsAli Kıvrak
Department of Cardiology Adana Numune Training and Research Hospital Adana Turkey
9 shared publicationsGökhan Gözübüyük
Adana Numune Training and Research Hospital, Department of Cardiology, Adana/Turkey
6 shared publicationsTaner Şeker
Department of Cardiology Adana Numune Training and Research Hospital Adana Turkey
6 shared publications
Latest Publications
- 22 August 2026
- Published by Springer Nature in Journal of Interventional Cardiac Electrophysiology
- Vol. 69 (9) , 3033-3046
The use of high-density electroanatomic mapping catheter (Advisor™ HD Grid) in detecting critical Purkinje potentials (P1-P2) in patients with left posterior fascicular VT
Background In patients with left posterior fascicular ventricular tachycardia (LPF-VT), the most critical determinant of successful radiofrequency ablation (RFA) is the accurate identification of the antegrade and retrograde pathways (P1–P2) within the reentrant circuit. The aim of this study was to evaluate the impact of HD Grid–guided RFA on P1 potential detection, procedural duration, acute procedural success, and arrhythmic recurrence in patients with LPF-VT. Methods In this retrospective-cohort study, 25-patients with inducible tachycardia during electrophysiological study and a confirmed diagnosis of LPF-VT were included. Patients were divided into two-groups according to the use of the HD Grid Mapping Catheter during RFA: standard RFA group (Group-I) and standard RFA + HD Grid group (Group-II). Patients were followed for a mean duration of 24.8 ± 14.8 months after RFA. Results In Group-II, the frequency of P1 recording during VT and, consequently, P1-targeted RF applications was significantly higher than in Group-I (92% vs 39%, and, p = 0.008). Acute procedural success was achieved in all 12-patients (100%) in Group-II and in 9-patients (69%) in Group-I (p < 0.047). During follow-up, LPF-VT recurrence occurred in 7-patients (54%) in Group-I and 1-patient (8%) in Group-II (p < 0.020). Conclusion In this study, the use of the HD Grid Mapping Catheter during RFA for LPF-VT was associated with a higher detection rate of P1 potentials compared with the standard RFA approach. Given the critical role of P1 potentials in determining procedural success, this finding may suggest a potential relationship with shorter procedural and fluoroscopy times, higher acute procedural success rates, and lower LPF-VT recurrence rates in this patient population. Graphical abstract
- 22 August 2026
- Published by Springer Nature in Journal of Interventional Cardiac Electrophysiology
- Vol. 69 (9) , 3033-3046
The use of high-density electroanatomic mapping catheter (Advisor™ HD Grid) in detecting critical Purkinje potentials (P1-P2) in patients with left posterior fascicular VT
Background In patients with left posterior fascicular ventricular tachycardia (LPF-VT), the most critical determinant of successful radiofrequency ablation (RFA) is the accurate identification of the antegrade and retrograde pathways (P1–P2) within the reentrant circuit. The aim of this study was to evaluate the impact of HD Grid–guided RFA on P1 potential detection, procedural duration, acute procedural success, and arrhythmic recurrence in patients with LPF-VT. Methods In this retrospective-cohort study, 25-patients with inducible tachycardia during electrophysiological study and a confirmed diagnosis of LPF-VT were included. Patients were divided into two-groups according to the use of the HD Grid Mapping Catheter during RFA: standard RFA group (Group-I) and standard RFA + HD Grid group (Group-II). Patients were followed for a mean duration of 24.8 ± 14.8 months after RFA. Results In Group-II, the frequency of P1 recording during VT and, consequently, P1-targeted RF applications was significantly higher than in Group-I (92% vs 39%, and, p = 0.008). Acute procedural success was achieved in all 12-patients (100%) in Group-II and in 9-patients (69%) in Group-I (p < 0.047). During follow-up, LPF-VT recurrence occurred in 7-patients (54%) in Group-I and 1-patient (8%) in Group-II (p < 0.020). Conclusion In this study, the use of the HD Grid Mapping Catheter during RFA for LPF-VT was associated with a higher detection rate of P1 potentials compared with the standard RFA approach. Given the critical role of P1 potentials in determining procedural success, this finding may suggest a potential relationship with shorter procedural and fluoroscopy times, higher acute procedural success rates, and lower LPF-VT recurrence rates in this patient population. Graphical abstract
- 28 January 2026
- Published by Wiley in Journal of Cardiovascular Electrophysiology
- Vol. 37 (4) , 714-723
A Single 480‐s Cryoablation Reduces Long‐Term Arrhythmia Recurrence Rate Than Standard Cryoablation in Patients With AVNRT
Introduction: Focal cryoablation (CRYO) is an alternative to radiofrequency ablation (RFA) in patients with atrioventricular nodal reentrant tachycardia (AVNRT) with low risk of atrioventricular (AV) block and high arrhythmia recurrence. There are limited studies showing that longer duration and bonus CRYO decreases arrhythmia recurrence compared to standard CRYO (two times 240 s). In our study, it was planned to investigate the efficacy of a single 480‐s CRYO protocol on the long‐term risk of AVNRT recurrence and persistent AV block in AVNRT patients compared to standard CRYO and RFA protocols. Methods: Two hundred sixty patients who underwent ablation for AVNRT were enrolled in this retrospective cohort study. Patients were divided into three groups: standard CRYO group (Group I), single 480‐s CRYO group (Group II), and RFA group (Group III). Groups I, II, and III included 92, 68, and 100 AVNRT patients, respectively. Patients were followed for 32 ± 9.1 months after ablation. The groups were compared for acute process success, transient AV block, persistent AV block, and long‐term arrhythmic recurrence. Results: In the follow‐up, AVNRT recurrence was determined in 10, 2, and 3 patients in Groups I, II, and III, respectively ( p < 0.001). The frequency of AVNRT recurrence was significantly higher in Group I than in Groups II and III ( p < 0.05). It was found that the frequency of AVNRT recurrence was similar between Groups II and III. In Groups I and II, permanent AV block associated with ablation was not observed in either case. However, in Group III, only two patients were found to have permanent AV block. There were no statistical differences between groups in terms of permanent AV block development. Acute process success and transient AV block development were similar among groups. Discussion: In our study, it was shown that AVNRT patients can be treated effectively and safely with a single 480‐s CRYO protocol among catheter ablation methods. While this new CRYO protocol significantly reduces the long‐term arrhythmic recurrence rate compared to standard CRYO, it is similarly effective with RFA.
- 28 January 2026
- Published by Wiley in Journal of Cardiovascular Electrophysiology
- Vol. 37 (4) , 714-723
A Single 480‐s Cryoablation Reduces Long‐Term Arrhythmia Recurrence Rate Than Standard Cryoablation in Patients With AVNRT
Introduction: Focal cryoablation (CRYO) is an alternative to radiofrequency ablation (RFA) in patients with atrioventricular nodal reentrant tachycardia (AVNRT) with low risk of atrioventricular (AV) block and high arrhythmia recurrence. There are limited studies showing that longer duration and bonus CRYO decreases arrhythmia recurrence compared to standard CRYO (two times 240 s). In our study, it was planned to investigate the efficacy of a single 480‐s CRYO protocol on the long‐term risk of AVNRT recurrence and persistent AV block in AVNRT patients compared to standard CRYO and RFA protocols. Methods: Two hundred sixty patients who underwent ablation for AVNRT were enrolled in this retrospective cohort study. Patients were divided into three groups: standard CRYO group (Group I), single 480‐s CRYO group (Group II), and RFA group (Group III). Groups I, II, and III included 92, 68, and 100 AVNRT patients, respectively. Patients were followed for 32 ± 9.1 months after ablation. The groups were compared for acute process success, transient AV block, persistent AV block, and long‐term arrhythmic recurrence. Results: In the follow‐up, AVNRT recurrence was determined in 10, 2, and 3 patients in Groups I, II, and III, respectively ( p < 0.001). The frequency of AVNRT recurrence was significantly higher in Group I than in Groups II and III ( p < 0.05). It was found that the frequency of AVNRT recurrence was similar between Groups II and III. In Groups I and II, permanent AV block associated with ablation was not observed in either case. However, in Group III, only two patients were found to have permanent AV block. There were no statistical differences between groups in terms of permanent AV block development. Acute process success and transient AV block development were similar among groups. Discussion: In our study, it was shown that AVNRT patients can be treated effectively and safely with a single 480‐s CRYO protocol among catheter ablation methods. While this new CRYO protocol significantly reduces the long‐term arrhythmic recurrence rate compared to standard CRYO, it is similarly effective with RFA.
- Open Access
- 1 August 2025
- Published by Wolters Kluwer Health in Medicine
- Vol. 104 (31) , e43642
Predictive value of immune inflammation index and systemic inflammation response index for contrast-induced acute kidney injury in endovascular treatment for acute ischemic stroke
Endovascular treatment (EVT) is the treatment method for acute ischemic stroke (AIS) caused by large vessel occlusion. Contrast-induced acute kidney injury (CI-AKI) is a relatively common complication. In this study, we aimed to investigate the incidence and possible risk factors of CI-AKI including systemic inflammation response index (SIRI) and systemic immune inflammation index (SII) in patients undergoing mechanical thrombectomy. We retrospectively analyzed patients who underwent EVT for acute cerebral large vessel occlusion between January 1, 2021, and March 31, 2024. Before the intervention, blood was drawn from the antecubital vein and collected in the appropriate tubes. Serum levels of neutrophils, lymphocytes, platelets, hemoglobin, CRP, and albumin were measured, alongside lipid profiles and liver and kidney function parameters. An increase in serum creatinine of 0.5 mg/dL or more than 25% in the measurements 48 to 72 hours after EVT compared to before was defined as CI-AKI. SII was calculated with the formula of: peripheral (platelet count × neutrophil count)/ lymphocyte count; SIRI was calculated with the formula of: (neutrophil count × monocyte count)/ lymphocyte count. Their predictive value for CI-AKI occurrence was compared. CI-AKI was detected in 54 (19%) of the 281 patients included in the study. In terms of clinical parameters, baseline NIHSS, postthrombectomy, cerebral edema, hemorrhagic transformation, recanalization time, discharge mRS and contrast amount were significantly higher in patients with CI-AKI. SII exhibited the highest discriminative performance in predicting CI-AKI in patients undergoing mechanical thrombectomy, with a threshold of > 1784 (AUC = 0.710, 95% CI: 0.631–0.788, P < .001, sensitivity 42.6%, specificity 89.0%) followed by SIRI (AUC = 0.652, 95% CI: 0.576–0.728, P < .001, sensitivity 88.9%, specificity 37.9%). SII and SIRI were found to be significantly higher in patients with CI-AKI. These scores may be new promising low-grade inflammatory indicators for predicting CI-AKI development.
- 1 August 2025
- Published by Wolters Kluwer Health in Medicine
- Vol. 104 (31) , e43642
Open AccessPredictive value of immune inflammation index and systemic inflammation response index for contrast-induced acute kidney injury in endovascular treatment for acute ischemic stroke
Endovascular treatment (EVT) is the treatment method for acute ischemic stroke (AIS) caused by large vessel occlusion. Contrast-induced acute kidney injury (CI-AKI) is a relatively common complication. In this study, we aimed to investigate the incidence and possible risk factors of CI-AKI including systemic inflammation response index (SIRI) and systemic immune inflammation index (SII) in patients undergoing mechanical thrombectomy. We retrospectively analyzed patients who underwent EVT for acute cerebral large vessel occlusion between January 1, 2021, and March 31, 2024. Before the intervention, blood was drawn from the antecubital vein and collected in the appropriate tubes. Serum levels of neutrophils, lymphocytes, platelets, hemoglobin, CRP, and albumin were measured, alongside lipid profiles and liver and kidney function parameters. An increase in serum creatinine of 0.5 mg/dL or more than 25% in the measurements 48 to 72 hours after EVT compared to before was defined as CI-AKI. SII was calculated with the formula of: peripheral (platelet count × neutrophil count)/ lymphocyte count; SIRI was calculated with the formula of: (neutrophil count × monocyte count)/ lymphocyte count. Their predictive value for CI-AKI occurrence was compared. CI-AKI was detected in 54 (19%) of the 281 patients included in the study. In terms of clinical parameters, baseline NIHSS, postthrombectomy, cerebral edema, hemorrhagic transformation, recanalization time, discharge mRS and contrast amount were significantly higher in patients with CI-AKI. SII exhibited the highest discriminative performance in predicting CI-AKI in patients undergoing mechanical thrombectomy, with a threshold of > 1784 (AUC = 0.710, 95% CI: 0.631–0.788, P < .001, sensitivity 42.6%, specificity 89.0%) followed by SIRI (AUC = 0.652, 95% CI: 0.576–0.728, P < .001, sensitivity 88.9%, specificity 37.9%). SII and SIRI were found to be significantly higher in patients with CI-AKI. These scores may be new promising low-grade inflammatory indicators for predicting CI-AKI development.
- 29 July 2025
- Published by Springer Nature in Bratislava Medical Journal
- Vol. 126 (11) , 3097-3108
Catheter Ablation Reduces Long-Term Adverse Renal Events in Atrial Fibrillation Patients with Chronic Kidney Disease
- 29 July 2025
- Published by Springer Nature in Bratislava Medical Journal
- Vol. 126 (11) , 3097-3108
Catheter Ablation Reduces Long-Term Adverse Renal Events in Atrial Fibrillation Patients with Chronic Kidney Disease
- 1 January 2022
- Published by Elsevier in Journal of Electrocardiology
- Vol. 70, 30-34
V1r + DIIq is a novel and accurate criterion to predict right vs. left paraseptal accessory pathways
- 1 January 2022
- Published by Elsevier in Journal of Electrocardiology
- Vol. 70, 30-34
V1r + DIIq is a novel and accurate criterion to predict right vs. left paraseptal accessory pathways
- Retraction
- 19 November 2019
- Published by Elsevier in Journal of Cardiology Cases
- Vol. 26 (6) , 436
Retraction notice to “Successful treatment for a giant coronary saccular aneurysm complicated with myocardial infarction in a patient with Behcet’s disease: Case report” [J Cardiol Cases 6(4) (2012) e118–e120]
- 19 November 2019
- Published by Elsevier in Journal of Cardiology Cases
- Vol. 26 (6) , 436
RetractionRetraction notice to “Successful treatment for a giant coronary saccular aneurysm complicated with myocardial infarction in a patient with Behcet’s disease: Case report” [J Cardiol Cases 6(4) (2012) e118–e120]
- Open Access
- 1 January 2018
- Published by XMLink in Korean Circulation Journal
- Vol. 48 (10) , 920-929
Fibrosis Marker Soluble ST2 Predicts Atrial Fibrillation Recurrence after Cryoballoon Catheter Ablation of Nonvalvular Paroxysmal Atrial Fibrillation
Okar S, et al. Korean Circ J. 2016 Sep;48:e78. https://doi.org/10.4070/kcj.2018.0047
- 1 January 2018
- Published by XMLink in Korean Circulation Journal
- Vol. 48 (10) , 920-929
Open AccessFibrosis Marker Soluble ST2 Predicts Atrial Fibrillation Recurrence after Cryoballoon Catheter Ablation of Nonvalvular Paroxysmal Atrial Fibrillation
Okar S, et al. Korean Circ J. 2016 Sep;48:e78. https://doi.org/10.4070/kcj.2018.0047
- 23 April 2016
- Published by Springer Nature in Journal of Medical Ultrasonics
- Vol. 43 (3) , 435-438
Double steal phenomenon secondary to innominate artery occlusion
Innominate artery steno-occlusive disease is a relatively rare clinical entity and may cause cerebrovascular symptoms. Herein, we report a 50-year-old male patient who presented with recurrent syncopal episodes and cerebrovascular ischemia. Color Doppler sonography revealed a distinctive flow pattern with partial and total flow reversal in the right internal carotid artery and vertebral artery, respectively. Further angiographic evaluation revealed complete occlusion of the innominate artery. Endovascular stenting was successful and enabled normal antegrade flow in the right common carotid and vertebral artery.
- 23 April 2016
- Published by Springer Nature in Journal of Medical Ultrasonics
- Vol. 43 (3) , 435-438
Double steal phenomenon secondary to innominate artery occlusion
Innominate artery steno-occlusive disease is a relatively rare clinical entity and may cause cerebrovascular symptoms. Herein, we report a 50-year-old male patient who presented with recurrent syncopal episodes and cerebrovascular ischemia. Color Doppler sonography revealed a distinctive flow pattern with partial and total flow reversal in the right internal carotid artery and vertebral artery, respectively. Further angiographic evaluation revealed complete occlusion of the innominate artery. Endovascular stenting was successful and enabled normal antegrade flow in the right common carotid and vertebral artery.
- 11 August 2013
- Published by Springer Nature in Herz
- Vol. 39 (6) , 761-766
Gamma glutamyl transferase activity
- 11 August 2013
- Published by Springer Nature in Herz
- Vol. 39 (6) , 761-766
Gamma glutamyl transferase activity
- 7 August 2013
- Published by Wiley in The Journal of Clinical Hypertension
- Vol. 15 (10) , 731-736
High‐Sensitivity Cardiac Troponin T Predicts Nondipper Hypertension in Newly Diagnosed Hypertensive Patients
The increased prognostic accuracy of the high‐sensitivity cardiac troponin T (hs‐cTnT) assay vs the conventional cTnT assay has recently been reported in hypertensive patients. The authors aimed to investigate the significance of serum hs‐cTnT marker for prediction of nondipper hypertension (HTN) in hypertensive patients. A total of 317 patients with newly diagnosed HTN were studied. The patients were divided into two groups: 198 dipper hypertensive patients (mean age, 51.7±5.1 years) and 119 nondipper hypertensive patients (mean age, 53.4±7.6 years). Hs‐cTnT and N‐terminal pro‐brain natriuretic peptide (NT‐proBNP) were measured in all patients. hs‐cTnT and NT‐proBNP were independent predictors for nondipper HTN (P<.05 for all). The cutoff value of hs‐cTnT obtained by the receiver operator curve analysis was 7.55 ng/L for the prediction of nondipper HTN (sensitivity: 79%, specificity: 70%; 95% confidence interval, 0.769–0.860; P<.001). In patients with HTN, higher serum concentration of hs‐cTnT even within normal range is an independent predictor of nondipper HTN.
- 7 August 2013
- Published by Wiley in The Journal of Clinical Hypertension
- Vol. 15 (10) , 731-736
High‐Sensitivity Cardiac Troponin T Predicts Nondipper Hypertension in Newly Diagnosed Hypertensive Patients
The increased prognostic accuracy of the high‐sensitivity cardiac troponin T (hs‐cTnT) assay vs the conventional cTnT assay has recently been reported in hypertensive patients. The authors aimed to investigate the significance of serum hs‐cTnT marker for prediction of nondipper hypertension (HTN) in hypertensive patients. A total of 317 patients with newly diagnosed HTN were studied. The patients were divided into two groups: 198 dipper hypertensive patients (mean age, 51.7±5.1 years) and 119 nondipper hypertensive patients (mean age, 53.4±7.6 years). Hs‐cTnT and N‐terminal pro‐brain natriuretic peptide (NT‐proBNP) were measured in all patients. hs‐cTnT and NT‐proBNP were independent predictors for nondipper HTN (P<.05 for all). The cutoff value of hs‐cTnT obtained by the receiver operator curve analysis was 7.55 ng/L for the prediction of nondipper HTN (sensitivity: 79%, specificity: 70%; 95% confidence interval, 0.769–0.860; P<.001). In patients with HTN, higher serum concentration of hs‐cTnT even within normal range is an independent predictor of nondipper HTN.